시장보고서
상품코드
1875652

약물 모델링 소프트웨어 시장 분석과 예측 : 유형별, 제품별, 서비스별, 기술별, 컴포넌트별, 용도별, 최종 사용자별, 모듈별, 도입 형태별, 기능별

Drug Modeling Software Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Component, Application, End User, Module, Deployment, Functionality

발행일: | 리서치사: Global Insight Services | 페이지 정보: 영문 385 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

약물 모델링 소프트웨어 시장은 2024년 101억 달러에서 2034년까지 246억 달러로 확대되어 CAGR 약 9.3%를 나타낼 것으로 예측됩니다. 약물 모델링 소프트웨어 시장은 약물의 상호작용을 시뮬레이션하고 약동학 및 약력학적 특성을 예측하는 플랫폼을 포함합니다. 이러한 도구는 가상 스크리닝, 분자 모델링 및 구조 기반 설계를 가능하게 함으로써 신약 개발을 가속화합니다. 제약기업이 비용효과와 시간효율이 뛰어난 솔루션을 요구하는 가운데, AI 및 머신러닝의 진보에 의한 예측 정밀도의 향상과 맞춤형 의료의 촉진을 원동력으로 하여 시장은 성장세가 높아지고 있습니다.

약물 모델링 소프트웨어 시장은 계산 생물학의 진보와 제약 업계의 정밀의료로의 전환을 원동력으로 견조한 성장을 이루고 있습니다. 이 시장에서 소프트웨어 분야가 주도적인 역할을 담당하고 있으며, 분자 모델링 및 시뮬레이션 툴이 가장 높은 성장률을 나타내는 하위 부문이 되고 있습니다. 이러한 도구는 복잡한 생물학적 과정의 이해와 신약 개발 과정의 가속화에 필수적입니다. 뒤를 이어 구조 기반 신약 개발 설계 분야는 특정 분자 구조를 정밀하게 표적하는 특성으로 인해 채용이 확대되고 있습니다. 인공지능(AI)과 머신러닝을 약물 모델링 소프트웨어에 통합하는 추세로 예측 정밀도를 높여 시장의 기세를 더욱 가속화하고 있습니다. 클라우드 기반 솔루션은 세계의 연구팀에 확장성과 공동 작업 기능을 제공하여 존재감을 높이고 있습니다. 한편, 데이터 보안 및 관리를 선호하는 조직에서는 On-Premise 솔루션이 여전히 중요한 위치를 차지하고 있습니다. 다양한 연구 요구를 충족시키기 위해 사용자 친화적인 인터페이스와 사용자 정의 가능한 기능에 대한 수요가 증가하고 있습니다. 주요 기업 간의 지속적인 혁신과 전략적 제휴로 시장은 성장을 지속할 것으로 예측됩니다.

시장 세분화
유형 약동학 모델링, 약력학 모델링, 메커니즘 기반 모델링, 통계 모델링, 머신러닝 모델
제품 독립형 소프트웨어, 통합 소프트웨어, 클라우드 기반 솔루션, On-Premise 솔루션
서비스 컨설팅, 배포 지원, 교육 및 지원, 맞춤설정
기술 인공지능, 빅데이터 분석, 고성능 컴퓨팅, 양자 컴퓨팅
구성요소 소프트웨어, 하드웨어, 서비스
용도 신약 개발, 임상시험, 전임상시험, 독성시험, 규제준수
최종 사용자 제약기업, 생명공학기업, 연구기관, 위탁연구기관, 학술기관
모듈 시뮬레이션, 시각화, 데이터 분석, 보고
도입 형태 클라우드, On-Premise, 하이브리드
기능 데이터 통합, 예측 분석, 워크플로 자동화, 위험 평가

약물 모델링 소프트웨어 시장의 시장 역학은 전략적 제품 투입과 경쟁력 있는 가격 전략을 특징으로 하는 상황을 보여줍니다. 주요 기업은 사용자 경험과 통합 기능 강화에 중점을 두고 혁신적인 솔루션을 활용하여 시장 점유율을 확대하고 있습니다. 의약품 개발 프로세스에서 정확성과 효율성의 필요성으로 인해 고급 약물 모델링 도구에 대한 수요가 급증하고 있습니다. 주요 제약 회사와 신흥 생명 공학 회사 모두 가격 전략은 가치 기반 제안과 일치합니다. 경쟁 벤치마킹 분야에서는 주요 기업들이 경쟁 우위를 유지하기 위해 자사 포트폴리오를 강화하고 있습니다. 규제의 영향은 매우 중요하며 엄격한 규정 준수 요구 사항이 시장 진입 및 확장 전략을 형성하고 있습니다. 북미와 유럽은 여전히 최전선에 위치하고 있으며 이 지역의 규제 체제가 세계 동향에 영향을 미치고 있습니다. 그러나 아시아태평양은 유리한 정부 정책과 R&D 투자 증가로 수익성이 높은 시장으로 부상하고 있습니다. 경쟁 구도는 기술력과 시장 도달범위를 강화하기 위한 전략적 제휴와 합병을 특징으로 합니다.

관세의 영향

세계적인 관세 상황과 지정학적 긴장은 특히 동아시아의 약물 모델링 소프트웨어 시장에 큰 영향을 미칩니다. 일본과 한국에서는 주요 경제국과의 무역 마찰의 격화를 받아 국내 소프트웨어 능력에 대한 투자 확대나 현지 바이오테크 기업과의 제휴가 진행되고 있습니다. 중국은 자급자족에 대한 전략적 초점을 통해 독자적인 약물 모델링 기술 개발을 가속화하고 무역 장벽의 영향을 완화하고 있습니다. 대만은 소프트웨어 개발에 중요한 역할을 하면서도 서구 시장과의 관계 강화를 통해 지정학적 위험을 회피하고 있습니다. 제약 R&D 소프트웨어의 상위 시장은 기술 진보와 정밀의료에 대한 수요에 힘입어 견조합니다. 2035년까지 시장은 혁신과 전략적 제휴로 성장할 것으로 예측됩니다. 반면 중동 분쟁은 세계 공급망의 혼란을 심화시켜 에너지 가격 상승을 통해 운영 비용에 영향을 미칠 수 있습니다.

주요 동향과 촉진요인

약물 모델링 소프트웨어 시장은 계산생물학과 바이오인포매틱스의 진보에 힘입어 견조한 성장을 이루고 있습니다. 주요 동향으로는 인공지능(AI)과 머신러닝의 통합을 들 수 있으며, 이들은 신약 개발 프로세스를 변화시키고 있습니다. 이러한 기술은 보다 정확한 시뮬레이션과 예측 모델링을 가능하게 하여 의약품 개발에 따른 시간과 비용을 절감합니다. 또 다른 중요한 추세는 클라우드 기반 플랫폼의 채택 확대입니다. 제약 기업에 확장성과 유연성을 결합한 솔루션을 제공하여 세계의 연구팀 간의 협력 강화 및 데이터 공유를 가능하게 함으로써 혁신과 효율성을 촉진합니다. 개인화된 의료에 대한 관심 증가는 또한 개인의 유전자 프로파일에 맞는 의약품 개발을 실현하는 고급 모델링 도구에 대한 수요를 견인하고 있습니다. 시장 성장 촉진요인으로는 만성 질환 증가 추세와 새로운 치료법에 대한 긴급한 필요를 들 수 있습니다. 규제 상의 지원과 정부의 신약 개발 이니셔티브에 대한 자금 제공도 시장 성장을 더욱 뒷받침하고 있습니다. 의료 인프라가 확대되고 연구개발에 대한 주목이 높아지고 있는 신흥 시장에는 수많은 기회가 존재하고 있습니다. 최첨단 기술을 활용하여 사용자 친화적이고 비용 효율적인 솔루션을 제공하는 기업은 큰 시장 점유율을 얻는 기회를 획득합니다. 제약업계가 진화를 지속하고 있는 가운데, 약물 모델링 소프트웨어 시장은 지속적인 확대가 전망되고 있습니다.

목차

제1장 약물 모델링 소프트웨어 시장 개요

  • 본 조사의 목적
  • 약물 모델링 소프트웨어 시장의 정의와 본 보고서의 조사 범위
  • 본 보고서의 제한 사항
  • 조사 대상 기간 및 통화
  • 조사 방법

제2장 주요 요약

제3장 시장에 관한 중요 인사이트

제4장 약물 모델링 소프트웨어 시장의 전망

  • 약물 모델링 소프트웨어 시장의 세분화
  • 시장 역학
  • Porter's Five Forces 분석
  • PESTLE 분석
  • 밸류체인 분석
  • 4P 모델
  • 앤소프 매트릭스

제5장 약물 모델링 소프트웨어 시장의 전략

  • 상위 시장 분석
  • 수급 분석
  • 소비자의 구매 의욕
  • 사례 연구 분석
  • 가격 분석
  • 규제 상황
  • 공급망 분석
  • 경쟁 제품 분석
  • 최근 동향

제6장 약물 모델링 소프트웨어 시장의 규모

  • 약물 모델링 소프트웨어 시장의 규모(금액 기준)
  • 약물 모델링 소프트웨어 시장의 규모(수량 기준)

제7장 약물 모델링 소프트웨어 시장(유형별)

  • 시장 개요
  • 약동학 모델링
  • 약력학적 모델링
  • 메커니즘 기반 모델링
  • 통계 모델링
  • 머신러닝 모델
  • 기타

제8장 약물 모델링 소프트웨어 시장(제품별)

  • 시장 개요
  • 독립형 소프트웨어
  • 통합 소프트웨어
  • 클라우드 기반 솔루션
  • On-Premise 솔루션
  • 기타

제9장 약물 모델링 소프트웨어 시장(서비스별)

  • 시장 개요
  • 컨설팅
  • 소개
  • 교육 및 지원
  • 커스터마이즈
  • 기타

제10장 약물 모델링 소프트웨어 시장(기술별)

  • 시장 개요
  • 인공지능
  • 빅데이터 분석
  • 고성능 컴퓨팅
  • 양자 컴퓨팅
  • 기타

제11장 약물 모델링 소프트웨어 시장(컴포넌트별)

  • 시장 개요
  • 소프트웨어
  • 하드웨어
  • 서비스
  • 기타

제12장 약물 모델링 소프트웨어 시장(용도별)

  • 시장 개요
  • 신약 개발
  • 임상시험
  • 전임상시험
  • 독성시험
  • 규제 준수
  • 기타

제13장 약물 모델링 소프트웨어 시장(최종사용자별)

  • 시장 개요
  • 제약회사
  • 생명공학 기업
  • 연구기관
  • 수탁연구기관
  • 학술기관
  • 기타

제14장 약물 모델링 소프트웨어 시장(모듈별)

  • 시장 개요
  • 시뮬레이션
  • 시각화
  • 데이터 분석
  • 보고
  • 기타

제15장 약물 모델링 소프트웨어 시장(도입 형태별)

  • 시장 개요
  • 클라우드
  • On-Premise
  • 하이브리드
  • 기타

제16장 약물 모델링 소프트웨어 시장(기능별)

  • 시장 개요
  • 데이터 통합
  • 예측 분석
  • 워크플로 자동화
  • 리스크 평가
  • 기타

제17장 약물 모델링 소프트웨어 시장(지역별)

  • 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 네덜란드
    • 스웨덴
    • 스위스
    • 덴마크
    • 핀란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 싱가포르
    • 인도네시아
    • 대만
    • 말레이시아
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타 라틴아메리카 국가
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 남아프리카
    • 기타 중동 및 아프리카

제18장 경쟁 구도

  • 개요
  • 시장 점유율 분석
  • 주요 기업의 포지셔닝
  • 경쟁 리더십 매핑
  • 벤더 벤치마킹
  • 개발 전략 벤치마킹

제19장 기업 프로파일

  • Schrodinger
  • Certara
  • Simulations Plus
  • Molecular Devices
  • OpenEye Scientific Software
  • Chemical Computing Group
  • BioSolveIT
  • Optibrium
  • Nimbus Therapeutics
  • Cresset
  • PharmAI
  • Inte:Ligand
  • SilcsBio
  • Molsoft
  • LeadScope
  • Acellera
  • Collaborations Pharmaceuticals
  • MolPort
  • Cloud Pharmaceuticals
  • Molecular Networks
CSM 25.12.11

Drug Modeling Software Market is anticipated to expand from $10.1 billion in 2024 to $24.6 billion by 2034, growing at a CAGR of approximately 9.3%. The Drug Modeling Software Market encompasses platforms that simulate drug interactions and predict pharmacokinetic and pharmacodynamic properties. These tools accelerate drug discovery by enabling virtual screening, molecular modeling, and structure-based design. As pharmaceutical companies seek cost-effective and time-efficient solutions, the market is poised for growth, driven by advancements in AI and machine learning, enhancing predictive accuracy and fostering personalized medicine.

The Drug Modeling Software Market is experiencing robust growth, propelled by advancements in computational biology and the pharmaceutical industry's shift towards precision medicine. Within this market, the software segment leads, with molecular modeling and simulation tools being the top-performing sub-segments. These tools are vital for understanding complex biological processes and accelerating drug discovery. Following closely is the structure-based drug design segment, which benefits from increased adoption due to its precision in targeting specific molecular structures. The integration of artificial intelligence and machine learning into drug modeling software is enhancing predictive accuracy, further driving market momentum. Cloud-based solutions are gaining prominence, offering scalability and collaborative capabilities for global research teams. In contrast, on-premise solutions remain significant for organizations prioritizing data security and control. The demand for user-friendly interfaces and customizable features is on the rise, catering to diverse research needs. Continuous innovation and strategic collaborations among key players are anticipated to sustain market growth.

Market Segmentation
TypePharmacokinetic Modeling, Pharmacodynamic Modeling, Mechanistic Modeling, Statistical Modeling, Machine Learning Models
ProductStandalone Software, Integrated Software, Cloud-based Solutions, On-premise Solutions
ServicesConsulting, Implementation, Training and Support, Customization
TechnologyArtificial Intelligence, Big Data Analytics, High-performance Computing, Quantum Computing
ComponentSoftware, Hardware, Services
ApplicationDrug Discovery, Clinical Trials, Preclinical Studies, Toxicology Testing, Regulatory Compliance
End UserPharmaceutical Companies, Biotechnology Companies, Research Institutes, Contract Research Organizations, Academic Institutions
ModuleSimulation, Visualization, Data Analysis, Reporting
DeploymentCloud, On-premise, Hybrid
FunctionalityData Integration, Predictive Analysis, Workflow Automation, Risk Assessment

Drug modeling software market dynamics reveal a landscape marked by strategic product launches and competitive pricing strategies. Key players are leveraging innovative solutions to capture increased market share, with a focus on enhancing user experience and integration capabilities. The industry is witnessing a surge in demand for advanced drug modeling tools, driven by the need for precision and efficiency in drug discovery processes. The pricing strategies are aligned with value-based propositions, catering to both large pharmaceutical companies and emerging biotech firms. In the realm of competition benchmarking, leading companies are enhancing their portfolios to maintain competitive edges. Regulatory influences are pivotal, with stringent compliance requirements shaping market entry and expansion strategies. North America and Europe remain at the forefront, with regulatory frameworks influencing global market trends. The Asia-Pacific region, however, is emerging as a lucrative market due to favorable government policies and increased R&D investments. The competitive landscape is characterized by strategic alliances and mergers, aimed at bolstering technological capabilities and market reach.

Tariff Impact:

The global tariff landscape and geopolitical tensions are significantly influencing the Drug Modeling Software Market, particularly in East Asia. In Japan and South Korea, escalating trade tensions with major economies are prompting increased investments in domestic software capabilities and partnerships with local biotech firms. China's strategic focus on self-reliance is accelerating its development of proprietary drug modeling technologies, mitigating the impact of trade barriers. Taiwan, while a pivotal player in software development, navigates geopolitical risks by strengthening ties with Western markets. The parent market of pharmaceutical R&D software is robust, driven by technological advancements and the demand for precision medicine. By 2035, the market is projected to thrive on innovation and strategic alliances. Meanwhile, Middle East conflicts could exacerbate global supply chain disruptions and elevate energy prices, affecting operational costs.

Geographical Overview:

The drug modeling software market is witnessing robust growth across various regions, each with unique opportunities. North America remains at the forefront, driven by extensive R&D activities and the adoption of advanced technologies in drug discovery. The presence of major pharmaceutical companies and significant investment in healthcare IT further bolster the market. Europe follows closely, with a strong focus on precision medicine and personalized healthcare. The region's regulatory support for innovation in drug development enhances its market prospects. In the Asia Pacific, rapid technological advancements and increasing healthcare expenditures are fueling market expansion. Countries like China and India are emerging as key growth pockets, with substantial investments in pharmaceutical research and development. Latin America and the Middle East & Africa are gaining attention as emerging markets. Latin America benefits from improving healthcare infrastructure and rising demand for innovative drug solutions. Meanwhile, the Middle East & Africa are recognizing the potential of drug modeling software in enhancing healthcare outcomes.

Key Trends and Drivers:

The Drug Modeling Software Market is experiencing robust growth fueled by advancements in computational biology and bioinformatics. Key trends include the integration of artificial intelligence and machine learning, which is transforming drug discovery processes. These technologies enable more accurate simulations and predictive modeling, reducing the time and cost associated with drug development. Another significant trend is the increasing adoption of cloud-based platforms, which offer scalable and flexible solutions for pharmaceutical companies. This shift allows for enhanced collaboration and data sharing across research teams globally, facilitating innovation and efficiency. The growing emphasis on personalized medicine is also driving demand for sophisticated modeling tools that can tailor drug development to individual genetic profiles. Drivers of this market include the rising prevalence of chronic diseases and the urgent need for novel therapeutics. Regulatory support and government funding for drug discovery initiatives further bolster market growth. Opportunities abound in emerging markets where healthcare infrastructure is expanding, and there is a growing focus on research and development. Companies that leverage cutting-edge technologies and offer user-friendly, cost-effective solutions are well-positioned to capture significant market share. As the pharmaceutical industry continues to evolve, the Drug Modeling Software Market is poised for sustained expansion.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Drug Modeling Software Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Drug Modeling Software Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Component
  • 2.8 Key Highlights of the Market, by Application
  • 2.9 Key Highlights of the Market, by End User
  • 2.10 Key Highlights of the Market, by Module
  • 2.11 Key Highlights of the Market, by Deployment
  • 2.12 Key Highlights of the Market, by Functionality
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Component
  • 3.7 Market Attractiveness Analysis, by Application
  • 3.8 Market Attractiveness Analysis, by End User
  • 3.9 Market Attractiveness Analysis, by Module
  • 3.10 Market Attractiveness Analysis, by Deployment
  • 3.11 Market Attractiveness Analysis, by Functionality
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: Drug Modeling Software Market Outlook

  • 4.1 Drug Modeling Software Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Drug Modeling Software Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Drug Modeling Software Market Size

  • 6.1 Drug Modeling Software Market Size, by Value
  • 6.2 Drug Modeling Software Market Size, by Volume

7: Drug Modeling Software Market, by Type

  • 7.1 Market Overview
  • 7.2 Pharmacokinetic Modeling
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Pharmacodynamic Modeling
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Mechanistic Modeling
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Statistical Modeling
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Machine Learning Models
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region
  • 7.7 Others
    • 7.7.1 Key Market Trends & Opportunity Analysis
    • 7.7.2 Market Size and Forecast, by Region

8: Drug Modeling Software Market, by Product

  • 8.1 Market Overview
  • 8.2 Standalone Software
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Integrated Software
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Cloud-based Solutions
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 On-premise Solutions
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Others
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region

9: Drug Modeling Software Market, by Services

  • 9.1 Market Overview
  • 9.2 Consulting
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Implementation
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Training and Support
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Customization
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Others
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region

10: Drug Modeling Software Market, by Technology

  • 10.1 Market Overview
  • 10.2 Artificial Intelligence
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Big Data Analytics
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 High-performance Computing
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Quantum Computing
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Others
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region

11: Drug Modeling Software Market, by Component

  • 11.1 Market Overview
  • 11.2 Software
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Hardware
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Services
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Others
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region

12: Drug Modeling Software Market, by Application

  • 12.1 Market Overview
  • 12.2 Drug Discovery
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Clinical Trials
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Preclinical Studies
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Toxicology Testing
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Regulatory Compliance
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region
  • 12.7 Others
    • 12.7.1 Key Market Trends & Opportunity Analysis
    • 12.7.2 Market Size and Forecast, by Region

13: Drug Modeling Software Market, by End User

  • 13.1 Market Overview
  • 13.2 Pharmaceutical Companies
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Biotechnology Companies
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Research Institutes
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Contract Research Organizations
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region
  • 13.6 Academic Institutions
    • 13.6.1 Key Market Trends & Opportunity Analysis
    • 13.6.2 Market Size and Forecast, by Region
  • 13.7 Others
    • 13.7.1 Key Market Trends & Opportunity Analysis
    • 13.7.2 Market Size and Forecast, by Region

14: Drug Modeling Software Market, by Module

  • 14.1 Market Overview
  • 14.2 Simulation
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Visualization
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Data Analysis
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Reporting
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region
  • 14.6 Others
    • 14.6.1 Key Market Trends & Opportunity Analysis
    • 14.6.2 Market Size and Forecast, by Region

15: Drug Modeling Software Market, by Deployment

  • 15.1 Market Overview
  • 15.2 Cloud
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 On-premise
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Hybrid
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Others
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region

16: Drug Modeling Software Market, by Functionality

  • 16.1 Market Overview
  • 16.2 Data Integration
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 Predictive Analysis
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 Workflow Automation
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region
  • 16.5 Risk Assessment
    • 16.5.1 Key Market Trends & Opportunity Analysis
    • 16.5.2 Market Size and Forecast, by Region
  • 16.6 Others
    • 16.6.1 Key Market Trends & Opportunity Analysis
    • 16.6.2 Market Size and Forecast, by Region

17: Drug Modeling Software Market, by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Services
    • 17.2.5 North America Market Size and Forecast, by Technology
    • 17.2.6 North America Market Size and Forecast, by Component
    • 17.2.7 North America Market Size and Forecast, by Application
    • 17.2.8 North America Market Size and Forecast, by End User
    • 17.2.9 North America Market Size and Forecast, by Module
    • 17.2.10 North America Market Size and Forecast, by Deployment
    • 17.2.11 North America Market Size and Forecast, by Functionality
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Services
      • 17.2.9.4 United States Market Size and Forecast, by Technology
      • 17.2.9.5 United States Market Size and Forecast, by Component
      • 17.2.9.6 United States Market Size and Forecast, by Application
      • 17.2.9.7 United States Market Size and Forecast, by End User
      • 17.2.9.8 United States Market Size and Forecast, by Module
      • 17.2.9.9 United States Market Size and Forecast, by Deployment
      • 17.2.9.10 United States Market Size and Forecast, by Functionality
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Services
      • 17.2.10.4 Canada Market Size and Forecast, by Technology
      • 17.2.10.5 Canada Market Size and Forecast, by Component
      • 17.2.10.6 Canada Market Size and Forecast, by Application
      • 17.2.10.7 Canada Market Size and Forecast, by End User
      • 17.2.10.8 Canada Market Size and Forecast, by Module
      • 17.2.10.9 Canada Market Size and Forecast, by Deployment
      • 17.2.10.10 Canada Market Size and Forecast, by Functionality
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Services
    • 17.3.5 Europe Market Size and Forecast, by Technology
    • 17.3.6 Europe Market Size and Forecast, by Component
    • 17.3.7 Europe Market Size and Forecast, by Application
    • 17.3.8 Europe Market Size and Forecast, by End User
    • 17.3.9 Europe Market Size and Forecast, by Module
    • 17.3.10 Europe Market Size and Forecast, by Deployment
    • 17.3.11 Europe Market Size and Forecast, by Functionality
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 17.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.5 United Kingdom Market Size and Forecast, by Component
      • 17.3.9.6 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.7 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.8 United Kingdom Market Size and Forecast, by Module
      • 17.3.9.9 United Kingdom Market Size and Forecast, by Deployment
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Functionality
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Services
      • 17.3.10.4 Germany Market Size and Forecast, by Technology
      • 17.3.10.5 Germany Market Size and Forecast, by Component
      • 17.3.10.6 Germany Market Size and Forecast, by Application
      • 17.3.10.7 Germany Market Size and Forecast, by End User
      • 17.3.10.8 Germany Market Size and Forecast, by Module
      • 17.3.10.9 Germany Market Size and Forecast, by Deployment
      • 17.3.10.10 Germany Market Size and Forecast, by Functionality
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Services
      • 17.3.11.4 France Market Size and Forecast, by Technology
      • 17.3.11.5 France Market Size and Forecast, by Component
      • 17.3.11.6 France Market Size and Forecast, by Application
      • 17.3.11.7 France Market Size and Forecast, by End User
      • 17.3.11.8 France Market Size and Forecast, by Module
      • 17.3.11.9 France Market Size and Forecast, by Deployment
      • 17.3.11.10 France Market Size and Forecast, by Functionality
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Services
      • 17.3.12.4 Spain Market Size and Forecast, by Technology
      • 17.3.12.5 Spain Market Size and Forecast, by Component
      • 17.3.12.6 Spain Market Size and Forecast, by Application
      • 17.3.12.7 Spain Market Size and Forecast, by End User
      • 17.3.12.8 Spain Market Size and Forecast, by Module
      • 17.3.12.9 Spain Market Size and Forecast, by Deployment
      • 17.3.12.10 Spain Market Size and Forecast, by Functionality
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Services
      • 17.3.13.4 Italy Market Size and Forecast, by Technology
      • 17.3.13.5 Italy Market Size and Forecast, by Component
      • 17.3.13.6 Italy Market Size and Forecast, by Application
      • 17.3.13.7 Italy Market Size and Forecast, by End User
      • 17.3.13.8 Italy Market Size and Forecast, by Module
      • 17.3.13.9 Italy Market Size and Forecast, by Deployment
      • 17.3.13.10 Italy Market Size and Forecast, by Functionality
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Services
      • 17.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.5 Netherlands Market Size and Forecast, by Component
      • 17.3.14.6 Netherlands Market Size and Forecast, by Application
      • 17.3.14.7 Netherlands Market Size and Forecast, by End User
      • 17.3.14.8 Netherlands Market Size and Forecast, by Module
      • 17.3.14.9 Netherlands Market Size and Forecast, by Deployment
      • 17.3.14.10 Netherlands Market Size and Forecast, by Functionality
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Services
      • 17.3.15.4 Sweden Market Size and Forecast, by Technology
      • 17.3.15.5 Sweden Market Size and Forecast, by Component
      • 17.3.15.6 Sweden Market Size and Forecast, by Application
      • 17.3.15.7 Sweden Market Size and Forecast, by End User
      • 17.3.15.8 Sweden Market Size and Forecast, by Module
      • 17.3.15.9 Sweden Market Size and Forecast, by Deployment
      • 17.3.15.10 Sweden Market Size and Forecast, by Functionality
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Services
      • 17.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.5 Switzerland Market Size and Forecast, by Component
      • 17.3.16.6 Switzerland Market Size and Forecast, by Application
      • 17.3.16.7 Switzerland Market Size and Forecast, by End User
      • 17.3.16.8 Switzerland Market Size and Forecast, by Module
      • 17.3.16.9 Switzerland Market Size and Forecast, by Deployment
      • 17.3.16.10 Switzerland Market Size and Forecast, by Functionality
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Services
      • 17.3.17.4 Denmark Market Size and Forecast, by Technology
      • 17.3.17.5 Denmark Market Size and Forecast, by Component
      • 17.3.17.6 Denmark Market Size and Forecast, by Application
      • 17.3.17.7 Denmark Market Size and Forecast, by End User
      • 17.3.17.8 Denmark Market Size and Forecast, by Module
      • 17.3.17.9 Denmark Market Size and Forecast, by Deployment
      • 17.3.17.10 Denmark Market Size and Forecast, by Functionality
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Services
      • 17.3.18.4 Finland Market Size and Forecast, by Technology
      • 17.3.18.5 Finland Market Size and Forecast, by Component
      • 17.3.18.6 Finland Market Size and Forecast, by Application
      • 17.3.18.7 Finland Market Size and Forecast, by End User
      • 17.3.18.8 Finland Market Size and Forecast, by Module
      • 17.3.18.9 Finland Market Size and Forecast, by Deployment
      • 17.3.18.10 Finland Market Size and Forecast, by Functionality
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Services
      • 17.3.19.4 Russia Market Size and Forecast, by Technology
      • 17.3.19.5 Russia Market Size and Forecast, by Component
      • 17.3.19.6 Russia Market Size and Forecast, by Application
      • 17.3.19.7 Russia Market Size and Forecast, by End User
      • 17.3.19.8 Russia Market Size and Forecast, by Module
      • 17.3.19.9 Russia Market Size and Forecast, by Deployment
      • 17.3.19.10 Russia Market Size and Forecast, by Functionality
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by Component
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by Module
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by Deployment
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Functionality
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 17.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.6 Asia-Pacific Market Size and Forecast, by Component
    • 17.4.7 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.8 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.9 Asia-Pacific Market Size and Forecast, by Module
    • 17.4.10 Asia-Pacific Market Size and Forecast, by Deployment
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Functionality
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Services
      • 17.4.9.4 China Market Size and Forecast, by Technology
      • 17.4.9.5 China Market Size and Forecast, by Component
      • 17.4.9.6 China Market Size and Forecast, by Application
      • 17.4.9.7 China Market Size and Forecast, by End User
      • 17.4.9.8 China Market Size and Forecast, by Module
      • 17.4.9.9 China Market Size and Forecast, by Deployment
      • 17.4.9.10 China Market Size and Forecast, by Functionality
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Services
      • 17.4.10.4 India Market Size and Forecast, by Technology
      • 17.4.10.5 India Market Size and Forecast, by Component
      • 17.4.10.6 India Market Size and Forecast, by Application
      • 17.4.10.7 India Market Size and Forecast, by End User
      • 17.4.10.8 India Market Size and Forecast, by Module
      • 17.4.10.9 India Market Size and Forecast, by Deployment
      • 17.4.10.10 India Market Size and Forecast, by Functionality
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Services
      • 17.4.11.4 Japan Market Size and Forecast, by Technology
      • 17.4.11.5 Japan Market Size and Forecast, by Component
      • 17.4.11.6 Japan Market Size and Forecast, by Application
      • 17.4.11.7 Japan Market Size and Forecast, by End User
      • 17.4.11.8 Japan Market Size and Forecast, by Module
      • 17.4.11.9 Japan Market Size and Forecast, by Deployment
      • 17.4.11.10 Japan Market Size and Forecast, by Functionality
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Services
      • 17.4.12.4 South Korea Market Size and Forecast, by Technology
      • 17.4.12.5 South Korea Market Size and Forecast, by Component
      • 17.4.12.6 South Korea Market Size and Forecast, by Application
      • 17.4.12.7 South Korea Market Size and Forecast, by End User
      • 17.4.12.8 South Korea Market Size and Forecast, by Module
      • 17.4.12.9 South Korea Market Size and Forecast, by Deployment
      • 17.4.12.10 South Korea Market Size and Forecast, by Functionality
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Services
      • 17.4.13.4 Australia Market Size and Forecast, by Technology
      • 17.4.13.5 Australia Market Size and Forecast, by Component
      • 17.4.13.6 Australia Market Size and Forecast, by Application
      • 17.4.13.7 Australia Market Size and Forecast, by End User
      • 17.4.13.8 Australia Market Size and Forecast, by Module
      • 17.4.13.9 Australia Market Size and Forecast, by Deployment
      • 17.4.13.10 Australia Market Size and Forecast, by Functionality
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Services
      • 17.4.14.4 Singapore Market Size and Forecast, by Technology
      • 17.4.14.5 Singapore Market Size and Forecast, by Component
      • 17.4.14.6 Singapore Market Size and Forecast, by Application
      • 17.4.14.7 Singapore Market Size and Forecast, by End User
      • 17.4.14.8 Singapore Market Size and Forecast, by Module
      • 17.4.14.9 Singapore Market Size and Forecast, by Deployment
      • 17.4.14.10 Singapore Market Size and Forecast, by Functionality
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Services
      • 17.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.5 Indonesia Market Size and Forecast, by Component
      • 17.4.15.6 Indonesia Market Size and Forecast, by Application
      • 17.4.15.7 Indonesia Market Size and Forecast, by End User
      • 17.4.15.8 Indonesia Market Size and Forecast, by Module
      • 17.4.15.9 Indonesia Market Size and Forecast, by Deployment
      • 17.4.15.10 Indonesia Market Size and Forecast, by Functionality
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Services
      • 17.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.5 Taiwan Market Size and Forecast, by Component
      • 17.4.16.6 Taiwan Market Size and Forecast, by Application
      • 17.4.16.7 Taiwan Market Size and Forecast, by End User
      • 17.4.16.8 Taiwan Market Size and Forecast, by Module
      • 17.4.16.9 Taiwan Market Size and Forecast, by Deployment
      • 17.4.16.10 Taiwan Market Size and Forecast, by Functionality
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Services
      • 17.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.5 Malaysia Market Size and Forecast, by Component
      • 17.4.17.6 Malaysia Market Size and Forecast, by Application
      • 17.4.17.7 Malaysia Market Size and Forecast, by End User
      • 17.4.17.8 Malaysia Market Size and Forecast, by Module
      • 17.4.17.9 Malaysia Market Size and Forecast, by Deployment
      • 17.4.17.10 Malaysia Market Size and Forecast, by Functionality
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Component
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Module
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Deployment
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Functionality
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Services
    • 17.5.5 Latin America Market Size and Forecast, by Technology
    • 17.5.6 Latin America Market Size and Forecast, by Component
    • 17.5.7 Latin America Market Size and Forecast, by Application
    • 17.5.8 Latin America Market Size and Forecast, by End User
    • 17.5.9 Latin America Market Size and Forecast, by Module
    • 17.5.10 Latin America Market Size and Forecast, by Deployment
    • 17.5.11 Latin America Market Size and Forecast, by Functionality
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Services
      • 17.5.9.4 Brazil Market Size and Forecast, by Technology
      • 17.5.9.5 Brazil Market Size and Forecast, by Component
      • 17.5.9.6 Brazil Market Size and Forecast, by Application
      • 17.5.9.7 Brazil Market Size and Forecast, by End User
      • 17.5.9.8 Brazil Market Size and Forecast, by Module
      • 17.5.9.9 Brazil Market Size and Forecast, by Deployment
      • 17.5.9.10 Brazil Market Size and Forecast, by Functionality
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Services
      • 17.5.10.4 Mexico Market Size and Forecast, by Technology
      • 17.5.10.5 Mexico Market Size and Forecast, by Component
      • 17.5.10.6 Mexico Market Size and Forecast, by Application
      • 17.5.10.7 Mexico Market Size and Forecast, by End User
      • 17.5.10.8 Mexico Market Size and Forecast, by Module
      • 17.5.10.9 Mexico Market Size and Forecast, by Deployment
      • 17.5.10.10 Mexico Market Size and Forecast, by Functionality
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Services
      • 17.5.11.4 Argentina Market Size and Forecast, by Technology
      • 17.5.11.5 Argentina Market Size and Forecast, by Component
      • 17.5.11.6 Argentina Market Size and Forecast, by Application
      • 17.5.11.7 Argentina Market Size and Forecast, by End User
      • 17.5.11.8 Argentina Market Size and Forecast, by Module
      • 17.5.11.9 Argentina Market Size and Forecast, by Deployment
      • 17.5.11.10 Argentina Market Size and Forecast, by Functionality
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by Component
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by Module
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by Deployment
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Functionality
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 17.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.6 Middle East and Africa Market Size and Forecast, by Component
    • 17.6.7 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.8 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.9 Middle East and Africa Market Size and Forecast, by Module
    • 17.6.10 Middle East and Africa Market Size and Forecast, by Deployment
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Functionality
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by Component
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by Module
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by Deployment
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Functionality
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Services
      • 17.6.10.4 UAE Market Size and Forecast, by Technology
      • 17.6.10.5 UAE Market Size and Forecast, by Component
      • 17.6.10.6 UAE Market Size and Forecast, by Application
      • 17.6.10.7 UAE Market Size and Forecast, by End User
      • 17.6.10.8 UAE Market Size and Forecast, by Module
      • 17.6.10.9 UAE Market Size and Forecast, by Deployment
      • 17.6.10.10 UAE Market Size and Forecast, by Functionality
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Services
      • 17.6.11.4 South Africa Market Size and Forecast, by Technology
      • 17.6.11.5 South Africa Market Size and Forecast, by Component
      • 17.6.11.6 South Africa Market Size and Forecast, by Application
      • 17.6.11.7 South Africa Market Size and Forecast, by End User
      • 17.6.11.8 South Africa Market Size and Forecast, by Module
      • 17.6.11.9 South Africa Market Size and Forecast, by Deployment
      • 17.6.11.10 South Africa Market Size and Forecast, by Functionality
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by Component
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by Module
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by Deployment
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Functionality
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 Schrodinger
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 Certara
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 Simulations Plus
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 Molecular Devices
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 OpenEye Scientific Software
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 Chemical Computing Group
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 BioSolveIT
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 Optibrium
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 Nimbus Therapeutics
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 Cresset
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 PharmAI
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 Inte:Ligand
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 SilcsBio
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 Molsoft
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 LeadScope
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis
  • 19.16 Acellera
    • 19.16.1 Company Overview
    • 19.16.2 Company Snapshot
    • 19.16.3 Business Segments
    • 19.16.4 Business Performance
    • 19.16.5 Product Offerings
    • 19.16.6 Key Developmental Strategies
    • 19.16.7 SWOT Analysis
  • 19.17 Collaborations Pharmaceuticals
    • 19.17.1 Company Overview
    • 19.17.2 Company Snapshot
    • 19.17.3 Business Segments
    • 19.17.4 Business Performance
    • 19.17.5 Product Offerings
    • 19.17.6 Key Developmental Strategies
    • 19.17.7 SWOT Analysis
  • 19.18 MolPort
    • 19.18.1 Company Overview
    • 19.18.2 Company Snapshot
    • 19.18.3 Business Segments
    • 19.18.4 Business Performance
    • 19.18.5 Product Offerings
    • 19.18.6 Key Developmental Strategies
    • 19.18.7 SWOT Analysis
  • 19.19 Cloud Pharmaceuticals
    • 19.19.1 Company Overview
    • 19.19.2 Company Snapshot
    • 19.19.3 Business Segments
    • 19.19.4 Business Performance
    • 19.19.5 Product Offerings
    • 19.19.6 Key Developmental Strategies
    • 19.19.7 SWOT Analysis
  • 19.20 Molecular Networks
    • 19.20.1 Company Overview
    • 19.20.2 Company Snapshot
    • 19.20.3 Business Segments
    • 19.20.4 Business Performance
    • 19.20.5 Product Offerings
    • 19.20.6 Key Developmental Strategies
    • 19.20.7 SWOT Analysis
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제